Advanced search

Clinical response correlates with 4‐week post injection ustekinumab concentrations in moderate‐to‐severe psoriasis patients

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Van den Berghe, N, E De Keyser, Rani Soenen, L Meuleman, S Lanssens, A Gils, and Jo Lambert. 2019. “Clinical Response Correlates with 4‐week Post Injection Ustekinumab Concentrations in Moderate‐to‐severe Psoriasis Patients.” British Journal of Dermatology.
APA
Van den Berghe, N., De Keyser, E., Soenen, R., Meuleman, L., Lanssens, S., Gils, A., & Lambert, J. (2019). Clinical response correlates with 4‐week post injection ustekinumab concentrations in moderate‐to‐severe psoriasis patients. BRITISH JOURNAL OF DERMATOLOGY.
Vancouver
1.
Van den Berghe N, De Keyser E, Soenen R, Meuleman L, Lanssens S, Gils A, et al. Clinical response correlates with 4‐week post injection ustekinumab concentrations in moderate‐to‐severe psoriasis patients. BRITISH JOURNAL OF DERMATOLOGY. 2019;
MLA
Van den Berghe, N et al. “Clinical Response Correlates with 4‐week Post Injection Ustekinumab Concentrations in Moderate‐to‐severe Psoriasis Patients.” BRITISH JOURNAL OF DERMATOLOGY (2019): n. pag. Print.
@article{8617731,
  author       = {Van den Berghe, N and De Keyser, E and Soenen, Rani and Meuleman, L and Lanssens, S and Gils, A and Lambert, Jo},
  issn         = {0007-0963},
  journal      = {BRITISH JOURNAL OF DERMATOLOGY},
  language     = {eng},
  title        = {Clinical response correlates with 4‐week post injection ustekinumab concentrations in moderate‐to‐severe psoriasis patients},
  url          = {http://dx.doi.org/10.1111/bjd.18016},
  year         = {2019},
}

Altmetric
View in Altmetric